Skip to main navigation Skip to search Skip to main content

Digoxin-quinidine interaction in patients with chronic renal failure

  • P. E. Fenster
  • , W. D. Hager
  • , D. Perrier
  • , J. R. Powell
  • , P. E. Graves
  • , U. F. Michael

Research output: Contribution to journalArticlepeer-review

Abstract

We evaluated the effect of quinidine on digoxin pharmacokinetics in six patients with severe renal failure. Quinidine reduced the total body clearance of digoxin from 1.87 to 1.06 l/hour (p < 0.001), and prolonged the digoxin half-life of elimination from 5.20 to 9.61 days (p < 0.01). The digoxin volume of distribution was unchanged. Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin. The mean trough serum concentrations of quinidine ranged from 1.0 to 3.0 μg/ml. We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.

Original languageEnglish (US)
Pages (from-to)1277-1280
Number of pages4
JournalNuclear Physics A
Volume66
Issue number6 I
DOIs
StatePublished - 1982

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Digoxin-quinidine interaction in patients with chronic renal failure'. Together they form a unique fingerprint.

Cite this